• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    8.24 Down 0.23(2.72%) Apr 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.47
    Open:8.52
    Bid:8.10 x 1000
    Ask:8.88 x 2000
    1y Target Est:5.00
    Beta:2.46
    Next Earnings Date:N/A
    Day's Range:8.17 - 8.60
    52wk Range:3.79 - 9.45
    Volume:422,302
    Avg Vol (3m):613,471
    Market Cap:592.17M
    P/E (ttm):N/A
    EPS (ttm):-2.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NWBO

    Comparison

    Symbol% ChgMkt Cap
    NWBODown 2.72%592.17M
    AGENUp 1.69%514.20M
    DNDN 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):409.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops immunotherapy products to treat cancer in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback